Background illustration for clinical trials search

Paid Clinical Trials Connecticut

Discover 1,167 paid clinical trials in Connecticut. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.

Filter
1

Mechanisms of Diuretic Resistance in Heart Failure, Aim 3

for
Heart Failure, Diuretic Resistance
Location: New Haven CT
Sponsor: Yale University

Sex: All

Age: 18+

Code: NCT06209359

Phase 1, Recruiting

Pompe Disease Registry Protocol

for
Glycogen Storage Disease Type II, Pompe Disease
Location: Portland ME, Boston MA, Springfield MA, New Haven CT,
Sponsor: Genzyme, a Sanofi Company

Sex: All

Age: 0+

Code: NCT00231400

Recruiting

A Study of ASP3082 in Adults With Advanced Solid Tumors

for
Solid Tumor
Location: Boston MA, New Haven CT, New York NY, Hackensack NJ,
Sponsor: Astellas Pharma Inc

Sex: All

Age: 18+

Code: NCT05382559

Phase 1, Recruiting

Study of Mogamulizumab With DA-EPOCH or CHOEP in Patients With Aggressive T-cell Lymphoma

for
T Cell Lymphoma, T-cell Lymphoma
Location: New Haven CT, New York NY
Sponsor: Yale University

Sex: All

Age: 18+

Code: NCT05996185

Phase 2, Recruiting

Prism Adaptation Therapy (PAT) for Right Brain Stroke Rehabilitation

for
Spatial Neglect After Right Brain Stroke
Location: West Haven CT, Leeds MA, Cleveland OH, Decatur GA
Sponsor: VA Office of Research and Development

Sex: All

Age: 18+

Code: NCT05983185

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

A Study to Evaluate Mezigdomide, Bortezomib and Dexamethasone (MEZIVd) Versus Pomalidomide, Bortezomib and Dexamethasone (PVd) in Participants With Relapsed or Refractory Multiple Myeloma (RRMM)

for
Relapsed or Refractory Multiple Myeloma
Location: Boston MA, Shirley NY, Farmington CT, Lake Success NY,
Sponsor: Celgene

Sex: All

Age: 18+

Code: NCT05519085

Phase 3, Recruiting

Mechanisms of Diuretic Resistance in Heart Failure, Aim 2

for
Heart Failure
Location: New Haven CT
Sponsor: Yale University

Sex: All

Age: 18+

Code: NCT05753059

Phase 1, Recruiting

A Study With Eptinezumab in Adolescents (12-17 Years) With Chronic Migraine

for
Chronic Migraine in Children
Location: Stamford CT, Norfolk VA, Hialeah FL, Ajax, Tampa FL,
Sponsor: H. Lundbeck A/S

Sex: All

Age: 12 - 17

Code: NCT04965675

Phase 3, Recruiting

Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral antiCoagulation (LILAC-TIMI 76)

for
Atrial Fibrillation (AF)
Location: Mira Road, Halifax, Bangor ME, Fall River MA, Boston MA,
Sponsor: Anthos Therapeutics, Inc.

Sex: All

Age: 65+

Code: NCT05712200

Phase 3, Recruiting

Emergency Department-Initiated Medications for Alcohol Use Disorder

for
Alcohol Use Disorder
Location: New Haven CT
Sponsor: Yale University

Sex: All

Age: 18 - 70+

Code: NCT05827159

Phase 3, Recruiting

Fabry Disease Registry & Pregnancy Sub-registry

for
Fabry Disease
Location: St. John's, Halifax, Portland ME, Boston MA,
Sponsor: Genzyme, a Sanofi Company

Sex: All

Age: 0+

Code: NCT00196742

Recruiting

The Effect of Pulsed Electromagnetic Field Therapy on Patients With Low Back Pain

for
Low Back Pain
Location: Bridgeport CT
Sponsor: University of Bridgeport

Sex: All

Age: 18 - 70

Code: NCT03053375

Recruiting

Ethicon Pelvic Mesh Post Market Clinical Follow-up Registry

for
Stress Urinary Incontinence, Pelvic Organ Prolapse
Location: New Haven CT, Philadelphia PA, Durham NC, Pittsburgh PA
Sponsor: Ethicon, Inc.

Sex: Female

Age: 21+

Code: NCT04829175

Recruiting

A Clinical Trial to Assess COM503 in Participants With Advanced Solid Malignancies

for
Neoplasm, Cancer, Malignant Tumors
Location: Boston MA, New Haven CT, Fairfax VA, Grand Rapids MI,
Sponsor: Compugen Ltd

Sex: All

Age: 18+

Code: NCT06759649

Phase 1, Recruiting

A Study to Investigate the Efficacy and Safety of Anifrolumab Administered as Subcutaneous Injection and Added to Standard of Care Compared With Placebo Added to Standard of Care in Adult Participants With Idiopathic Inflammatory Myopathies (Polymyositis and Dermatomyositis)

for
Polymyositis, Dermatomyositis
Location: Boston MA, New Haven CT, Great Neck NY, Montreal,
Sponsor: AstraZeneca

Sex: All

Age: 18 - 70+

Code: NCT06455449

Phase 3, Recruiting

Open-Label Extension Study to Assess the Long-Term Safety and Tolerability of KarXT in Subjects With Psychosis Associated With Alzheimer's Disease (ADEPT-3)

for
Psychosis Associated With Alzheimer's Disease
Location: Farmington CT, Woodmere NY, West Palm Beach FL,
Sponsor: Karuna Therapeutics, Inc., a Bristol Myers Squibb company

Sex: All

Age: 55 - 70+

Code: NCT05980949

Phase 3, Recruiting

Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia (AML) (A MyeloMATCH Treatment Trial)

for
Acute Myeloid Leukemia
Location: Brunswick ME, Portland ME, Scarborough ME,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT06317649

Phase 2, Recruiting

A Study of Combination Chemotherapy for Patients With Newly Diagnosed DAWT and Relapsed FHWT

for
Anaplastic Kidney Wilms Tumor, Recurrent Kidney Wilms Tumor,
Location: St. John's, Halifax, Bangor ME, Scarborough ME,
Sponsor: Children's Oncology Group

Sex: All

Age: 0 - 30

Code: NCT04322318

Phase 2, Recruiting

Exploration of Synaptotrophic Effects of Psilocybin in Opioid Use Disorder (OUD)

for
Opioid Use Disorder
Location: New Haven CT
Sponsor: Yale University

Sex: All

Age: 25 - 55

Code: NCT06160284

Phase 1, Recruiting

A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy in Combination With Pembrolizumab in Patients With PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer (TROPION-Breast05)

for
Breast Cancer
Location: Providence RI, New Haven CT, Quebec, Stony Brook NY,
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT06103864

Phase 3, Recruiting

Popular cities in Connecticut

Connecticut stands out as a prime location for a wide variety of clinical trials, largely thanks to its robust healthcare system and renowned medical research institutions. Leading centers like Yale School of Medicine, UConn Health, and Jackson Laboratory for Genomic Medicine are at the forefront of groundbreaking studies in the state.

Combining a strong focus on innovation and precision medicine makes Connecticut an ideal destination for participants seeking advanced medical treatments and the opportunity to contribute to cutting-edge research.

Why choose Connecticut for clinical trials?

With a diverse and highly educated population, Connecticut offers distinct advantages for those participating in clinical trials, including the opportunity to enhance the reliability and depth of research findings. The vibrant population here makes clinical studies in Connecticut more comprehensive and representative.

By choosing to participate in a clinical trial in Connecticut, individuals contribute to groundbreaking medical research while benefiting from a well-established and supportive clinical research infrastructure, ultimately advancing healthcare for all.

Common conditions studied in Connecticut

Local regulations and guidelines

Benefits of participating in clinical trials

How to enroll in a clinical trial in Connecticut